Exploring Vascular Endothelial Growth Factor and Other Blood-Brain Barrier Biomarkers in Cognition of First-Episode Psychosis: An Observational Study.

IF 4.5 2区 医学 Q1 PSYCHIATRY
Alejandro Ballesteros, María Flores-Lopez, Ana M Sánchez-Torres, Gustavo J Gil-Berrozpe, Lucía Moreno-Izco, Ana Gavito, Antonia Serrano, Fernando Rodríguez de Fonseca, Manuel J Cuesta
{"title":"Exploring Vascular Endothelial Growth Factor and Other Blood-Brain Barrier Biomarkers in Cognition of First-Episode Psychosis: An Observational Study.","authors":"Alejandro Ballesteros, María Flores-Lopez, Ana M Sánchez-Torres, Gustavo J Gil-Berrozpe, Lucía Moreno-Izco, Ana Gavito, Antonia Serrano, Fernando Rodríguez de Fonseca, Manuel J Cuesta","doi":"10.4088/JCP.24m15486","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Cognitive deficits are a core feature of early stages of schizophrenia. However, according to neurodevelopmental models, the extent to which chemokines and growth factors are involved in cognitive function remains debatable. We aimed to investigate whether homeostatic/inflammatory chemokines and growth factors are associated with cognitive impairment in patients with first-episode psychosis (FEP) in remission.</p><p><p><b>Methods:</b> Fifty patients, 21 healthy siblings, and 24 controls participated in the study. The primary outcomes were associations between cognition and growth factors (brain-derived neurotrophic factor [BDNF] and vascular endothelial growth factor [VEGF]), homeostatic markers (CXCL12), and inflammatory chemokines (CCL2, CCL3, CX3CL1, and CCL11) using a whole-blood immunoassay procedure. Differences between the FEP group, siblings, and controls were also examined to understand distinct group profiles.</p><p><p><b>Results:</b> The VEGF levels were significantly higher in the FEP group than in the control group. High VEGF levels are significantly associated with lower social cognition scores. Moreover, a post hoc hierarchical regression model explained 34.5% of the variance in social cognition (<i>F</i><sub>11, 32 </sub>=1.533, <i>P</i>=.168), with inflammatory variables explaining 13.5% and VEGF showing statistical significance (β=-1.936, <i>P</i>=.022). No additional significant results were found for the other inflammatory biomarkers.</p><p><p><b>Conclusions:</b> Our preliminary results suggest that an increase in VEGF might help preserve social cognition after first- episode psychosis. These findings might suggest that a compensatory mechanism could outweigh other VEGF- related hypotheses, such as blood-brain barrier opening and chronic neuroinflammation. However, this hypothesis requires further investigation to address the methodological challenges of determining chemokine levels and controlling for confounding variables.</p>","PeriodicalId":50234,"journal":{"name":"Journal of Clinical Psychiatry","volume":"86 3","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4088/JCP.24m15486","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cognitive deficits are a core feature of early stages of schizophrenia. However, according to neurodevelopmental models, the extent to which chemokines and growth factors are involved in cognitive function remains debatable. We aimed to investigate whether homeostatic/inflammatory chemokines and growth factors are associated with cognitive impairment in patients with first-episode psychosis (FEP) in remission.

Methods: Fifty patients, 21 healthy siblings, and 24 controls participated in the study. The primary outcomes were associations between cognition and growth factors (brain-derived neurotrophic factor [BDNF] and vascular endothelial growth factor [VEGF]), homeostatic markers (CXCL12), and inflammatory chemokines (CCL2, CCL3, CX3CL1, and CCL11) using a whole-blood immunoassay procedure. Differences between the FEP group, siblings, and controls were also examined to understand distinct group profiles.

Results: The VEGF levels were significantly higher in the FEP group than in the control group. High VEGF levels are significantly associated with lower social cognition scores. Moreover, a post hoc hierarchical regression model explained 34.5% of the variance in social cognition (F11, 32 =1.533, P=.168), with inflammatory variables explaining 13.5% and VEGF showing statistical significance (β=-1.936, P=.022). No additional significant results were found for the other inflammatory biomarkers.

Conclusions: Our preliminary results suggest that an increase in VEGF might help preserve social cognition after first- episode psychosis. These findings might suggest that a compensatory mechanism could outweigh other VEGF- related hypotheses, such as blood-brain barrier opening and chronic neuroinflammation. However, this hypothesis requires further investigation to address the methodological challenges of determining chemokine levels and controlling for confounding variables.

探索血管内皮生长因子和其他血脑屏障生物标志物在首发精神病认知中的作用:一项观察性研究。
背景:认知缺陷是精神分裂症早期阶段的核心特征。然而,根据神经发育模型,趋化因子和生长因子参与认知功能的程度仍有争议。我们的目的是研究体内平衡/炎症趋化因子和生长因子是否与首发精神病(FEP)缓解期患者的认知障碍有关。方法:50例患者,21例健康兄弟姐妹,24例对照。主要结果是认知与生长因子(脑源性神经营养因子[BDNF]和血管内皮生长因子[VEGF])、稳态标志物(CXCL12)和炎症趋化因子(CCL2、CCL3、CX3CL1和CCL11)之间的关系。FEP组、兄弟姐妹和对照组之间的差异也被检查以了解不同的组概况。结果:FEP组血管内皮生长因子水平明显高于对照组。高VEGF水平与较低的社会认知得分显著相关。此外,事后层次回归模型解释了34.5%的社会认知方差(F11, 32 =1.533, P=.168),炎症变量解释了13.5%,VEGF具有统计学意义(β=-1.936, P=.022)。其他炎症生物标志物未发现其他显著结果。结论:我们的初步结果表明,VEGF的增加可能有助于保持首发精神病患者的社会认知能力。这些发现可能表明代偿机制可能超过其他与VEGF相关的假设,如血脑屏障打开和慢性神经炎症。然而,这一假设需要进一步调查,以解决确定趋化因子水平和控制混杂变量的方法学挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Psychiatry
Journal of Clinical Psychiatry 医学-精神病学
CiteScore
7.40
自引率
1.90%
发文量
0
审稿时长
3-8 weeks
期刊介绍: For over 75 years, The Journal of Clinical Psychiatry has been a leading source of peer-reviewed articles offering the latest information on mental health topics to psychiatrists and other medical professionals.The Journal of Clinical Psychiatry is the leading psychiatric resource for clinical information and covers disorders including depression, bipolar disorder, schizophrenia, anxiety, addiction, posttraumatic stress disorder, and attention-deficit/hyperactivity disorder while exploring the newest advances in diagnosis and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信